| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/JLB.2MR0717-310R |
| P698 | PubMed publication ID | 29345375 |
| P50 | author | Laura Fantuzzi | Q56333769 |
| Daniela Angela Covino | Q56810178 | ||
| Maria Cristina Gauzzi | Q56810183 | ||
| P2860 | cites work | Lambda interferon inhibits human immunodeficiency virus type 1 infection of macrophages | Q24650069 |
| Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity | Q24677778 | ||
| Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein | Q27860488 | ||
| Surfing the p53 network | Q28032484 | ||
| Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints | Q28266170 | ||
| DNA replication stress mediates APOBEC3 family mutagenesis in breast cancer | Q28830105 | ||
| HIV-1 Gag-virus-like particles inhibit HIV-1 replication in dendritic cells and T cells through IFN-α-dependent upregulation of APOBEC3G and 3F. | Q30418622 | ||
| Differences in APOBEC3G expression in CD4+ T helper lymphocyte subtypes modulate HIV-1 infectivity | Q33406252 | ||
| Reassessing the role of APOBEC3G in human immunodeficiency virus type 1 infection of quiescent CD4+ T-cells | Q33419833 | ||
| The antiviral factor APOBEC3G improves CTL recognition of cultured HIV-infected T cells | Q33615181 | ||
| 17β-estradiol protects primary macrophages against HIV infection through induction of interferon-alpha | Q33631612 | ||
| CCR6 ligands inhibit HIV by inducing APOBEC3G. | Q33697355 | ||
| APOBEC3B, a molecular driver of mutagenesis in human cancers | Q33743603 | ||
| Human Beta Defensin 2 Selectively Inhibits HIV-1 in Highly Permissive CCR6⁺CD4⁺ T Cells. | Q33753961 | ||
| Dial 9-1-1 for p53: mechanisms of p53 activation by cellular stress | Q33997846 | ||
| A common path to innate immunity to HIV-1 induced by Toll-like receptor ligands in primary human macrophages | Q34014512 | ||
| Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction | Q34020228 | ||
| APOBEC3A is a specific inhibitor of the early phases of HIV-1 infection in myeloid cells. | Q34037651 | ||
| Innate immune signaling induces high levels of TC-specific deaminase activity in primary monocyte-derived cells through expression of APOBEC3A isoforms | Q34107265 | ||
| Interferon-alpha Induces High Expression of APOBEC3G and STAT-1 in Vitro and in Vivo | Q34205642 | ||
| IFN-λ3 inhibits HIV infection of macrophages through the JAK-STAT pathway | Q34256897 | ||
| Evidence for APOBEC3B mutagenesis in multiple human cancers | Q34357412 | ||
| Elevated APOBEC3B correlates with poor outcomes for estrogen-receptor-positive breast cancers | Q34491947 | ||
| NFAT and IRF Proteins Regulate Transcription of the Anti-HIV Gene, APOBEC3G | Q34509329 | ||
| Endogenous CCL2 neutralization restricts HIV-1 replication in primary human macrophages by inhibiting viral DNA accumulation | Q35041156 | ||
| Structural variants of IFNα preferentially promote antiviral functions | Q35197399 | ||
| APOBEC3A cytidine deaminase induces RNA editing in monocytes and macrophages | Q35543248 | ||
| Target cell-mediated editing of HIV-1 cDNA by APOBEC3 proteins in human macrophages. | Q35599400 | ||
| DNA damage tumor suppressor genes and genomic instability | Q35755997 | ||
| APOBEC3G upregulation by alpha interferon restricts human immunodeficiency virus type 1 infection in human peripheral plasmacytoid dendritic cells | Q45397134 | ||
| IRF-4 expression in the human myeloid lineage: up-regulation during dendritic cell differentiation and inhibition by 1alpha,25-dihydroxyvitamin D3. | Q46437047 | ||
| The nerve growth factor reduces APOBEC3G synthesis and enhances HIV-1 transcription and replication in human primary macrophages. | Q54621358 | ||
| Myeloid differentiation and susceptibility to HIV-1 are linked to APOBEC3 expression | Q35850696 | ||
| Apoptosis and genomic instability | Q35876010 | ||
| APOBEC3G/3F mediates intrinsic resistance of monocyte-derived dendritic cells to HIV-1 infection | Q36228190 | ||
| The PKC/NF-κB signaling pathway induces APOBEC3B expression in multiple human cancers | Q36244879 | ||
| Transcriptional regulation of APOBEC3 antiviral immunity through the CBF-β/RUNX axis | Q36276957 | ||
| Deaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3G. | Q36328929 | ||
| The antiviral factor APOBEC3G enhances the recognition of HIV-infected primary T cells by natural killer cells. | Q36490746 | ||
| APOBEC-induced mutations in human cancers are strongly enriched on the lagging DNA strand during replication | Q36506737 | ||
| RIG-I activation inhibits HIV replication in macrophages | Q37022843 | ||
| Double-stranded RNA analog poly(I:C) inhibits human immunodeficiency virus amplification in dendritic cells via type I interferon-mediated activation of APOBEC3G. | Q37033387 | ||
| Functional Upregulation of the DNA Cytosine Deaminase APOBEC3B by Polyomaviruses. | Q37073310 | ||
| Diverse stresses dramatically alter genome-wide p53 binding and transactivation landscape in human cancer cells | Q37122075 | ||
| An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers | Q37211712 | ||
| Defining APOBEC3 expression patterns in human tissues and hematopoietic cell subsets | Q37333883 | ||
| Interleukin-27 inhibition of HIV-1 involves an intermediate induction of type I interferon | Q37334618 | ||
| IFN-ε protects primary macrophages against HIV infection | Q37469163 | ||
| The interface between the innate interferon response and expression of host retroviral restriction factors | Q37772341 | ||
| Innate immune evasion strategies by human immunodeficiency virus type 1. | Q38139934 | ||
| Advances in anti-viral immune defence: revealing the importance of the IFN JAK/STAT pathway. | Q38692134 | ||
| Human Papillomavirus 16 E6 Upregulates APOBEC3B via the TEAD Transcription Factor | Q38721814 | ||
| Classical NF-κB pathway is responsible for APOBEC3B expression in cancer cells. | Q38748945 | ||
| Modulating APOBEC expression enhances DNA vaccine immunogenicity | Q38870396 | ||
| Identification of APOBEC3B promoter elements responsible for activation by human papillomavirus type 16 E6. | Q38896105 | ||
| Interferon epsilon promotes HIV restriction at multiple steps of viral replication | Q39043504 | ||
| Increased APOBEC3B Predicts Worse Outcomes in Lung Cancer: A Comprehensive Retrospective Study | Q39852184 | ||
| Sp1 and Sp3 regulate basal transcription of the human APOBEC3G gene | Q40129583 | ||
| Distinct patterns of cytokine regulation of APOBEC3G expression and activity in primary lymphocytes, macrophages, and dendritic cells | Q40207497 | ||
| Interferon-inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication | Q40275011 | ||
| The Cytidine Deaminase APOBEC3 Family Is Subject to Transcriptional Regulation by p53. | Q40319984 | ||
| Plastic restriction of HIV-1 replication in human macrophages derived from M1/M2 polarized monocytes. | Q40473707 | ||
| Association of germline variants in the APOBEC3 region with cancer risk and enrichment with APOBEC-signature mutations in tumors | Q40513376 | ||
| Transcriptional regulation of APOBEC3G, a cytidine deaminase that hypermutates human immunodeficiency virus | Q40527917 | ||
| Increased expression with differential subcellular location of cytidine deaminase APOBEC3G in human CD4(+) T-cell activation and dendritic cell maturation. | Q40751332 | ||
| High APOBEC3B expression is a predictor of recurrence in patients with low-risk clear cell renal cell carcinoma | Q41688195 | ||
| The role of cytidine deaminases on innate immune responses against human viral infections. | Q41812539 | ||
| Differential expression of HIV-1 interfering factors in monocyte-derived macrophages stimulated with polarizing cytokines or interferons | Q42010307 | ||
| B-Myb Induces APOBEC3B Expression Leading to Somatic Mutation in Multiple Cancers | Q42253948 | ||
| IFN-α induces APOBEC3G, F, and A in immature dendritic cells and limits HIV-1 spread to CD4+ T cells. | Q42274165 | ||
| APOBEC3B mutagenesis in cancer | Q42396092 | ||
| The interferon-induced expression of APOBEC3G in human blood-brain barrier exerts a potent intrinsic immunity to block HIV-1 entry to central nervous system | Q42545124 | ||
| Alpha interferon potently enhances the anti-human immunodeficiency virus type 1 activity of APOBEC3G in resting primary CD4 T cells | Q42799017 | ||
| M1 polarization of human monocyte-derived macrophages restricts pre and postintegration steps of HIV-1 replication. | Q43837736 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 433-444 | |
| P577 | publication date | 2017-12-15 | |
| P1433 | published in | Journal of Leukocyte Biology | Q1524048 |
| P1476 | title | Understanding the regulation of APOBEC3 expression: Current evidence and much to learn | |
| P478 | volume | 103 |
Search more.